We use cookies to deliver our online services. Details of the cookies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you agree to our use of cookies. To close this message click close.

Considerations for Device Firms in the Wake of a String of Successful First Amendment Challenges to FDA's Regulation of Off-Label Speech

03 May 2016

Westlaw Journal

Over the past few years, we have witnessed an erosion of the Food and Drug Administration's restriction of off-label speech through several court cases that have challenged the constitutionality of these restrictions on manufacturers' speech.

Read More: Considerations for Device Firms in the Wake of a String of Successful First Amendment Challenges to FDA's Regulation of Off-Label Speech

The team

Loading data